Raghuram Selvaraju
Raghuram Selvaraju is a research analyst at H.C. Wainwright who focuses on biopharmaceutical companies. He recently initiated coverage of Alpha Cognition Inc., praising its lead product ZUNVEYL for its potential to improve treatment for neurodegenerative disorders and its favorable safety profile compared to existing therapies.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Raghuram Selvaraju initiated coverage of Alpha Cognition Inc. with a buy rating.
8